Acute pancreatitis Digestive System
Conditions
Interventions
There are 5 Work Packages (WP). These are complementary and intended to inform aspects of the final WP5 (see study summary graphic).
WP1: Survey
In order to ensure that themes addressed in the interv
Sponsors
University of Birmingham
Eligibility
Sex/Gender
All
Age
16 Years to 100 Years
Inclusion criteria
Inclusion criteria: WP1: Any lived experience of adult acute pancreatitis care in NHS as patient or carer, clinician providing NHS care to patients with acute pancreatitis in secondary or primary care. WP2: Adults (or their carers) with experience of acute pancreatitis care in the NHS within the preceeding six months. Ideally have a conversational standard of English, but translation can be arranged. WP3: Clinicians (surgeons, gastroenterologists, specialist nurses, allied health professionals, GPs) providing NHS care to patients with acute pancreatitis. WP4: People currently admitted to hospital for acute pancreatitis who are due to be discharged. Must be able to consent to participate. WP5: Any lived experience of adult acute pancreatitis care in NHS as patient or carer, clinician providing NHS care to patients with acute pancreatitis in secondary or primary care. Minimum age of participants in any work stream is 16 years old, and participants may be up to 100 years old.
Exclusion criteria
Exclusion criteria: WP1: Must be able to complete survey in English WP2: Must have experienced care as an adult WP3: Non UK clinical practice WP4: Unwilling to consent; no capacity to consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| WP1: Identification of the opportunities that exist to improve care after discharge from hospital following acute pancreatitis measured using survey of stakeholders to identify the key features and characteristics that define a ‘good’ follow-up pathway for patients with AP. Qualitative content analysis using a thematic approach at until saturation is reached (40 patients/ carers, 40 clinicians);WP2: Commentary describing the experiences of participants (patients and their carers) following discharge from hospital with acute pancreatitis measured using purposive selection of candidates completing an EoI to maximise sampling across collected descriptors (sex, ethnicity, aetiology, region), followed by semi-structure interviews (informed by analysis of WP1) and qualitative thematic analysis at Following analysis of WP1 to run concurrently with WP3 and WP4;WP3: Commentary describing the experiences of NHS clinicians with responsibilities for the care of patients with AP measured using purposive selection of candidates completing an EoI to maximise sampling across collected descriptors (sex, ethnicity, aetiology, region), followed by semi-structure interviews (informed by analysis of WP1) and qualitative thematic analysis at following analysis of WP1 to run concurrently with WP2 and WP4;WP4: Patient demographics, Patient co-morbidities, Prior diagnosis of mental health issues, Disease aetiology and inpatient treatment, Clinician planned follow-up on discharge measured using patient records at baseline;WP4: Alcohol usage measured using AUDIT-C PROM at baseline;WP4: Patient quality of life measured using EQ-5D-5L PROM at discharge, 7 days, 30 days, 3 months, 6 months;WP4: Patient anxiety measured using GAD-7 PROM at discharge, 7 days, 30 days, 3 months, 6 months;WP4: Patient depression measured using PHQ-9 PROM at discharge, 7 days, 30 days, 3 months, 6 months;WP4: Patient endocrine insufficiency score measured using PEI-Q PROM at discharge, 7 days, 30 days, 3 months, 6 m | — |
Countries
England, Scotland, United Kingdom
Contacts
Public ContactMichala Pettitt
Outcome results
None listed